Full Professor(heuristic)
Renal cell carcinoma treatment · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index40
i10-index85
Publications227
Citations21,191
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in patients with Merkel cell carcinoma and lymph node metastases. (Journal of Clinical Oncology)2026-06-03
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-20
Data may not be current
Find elsewhere
ORCID: 0000-0002-0399-0965